Rob Wright, chief editor of Life Science Leader, recently conducted a COVID-19 leadership roundtable with five biopharmaceutical CEOs via Zoom (view in full here). In this segment, four biopharma CEOs discuss challenges around manufacturing of biopharmaceuticals during the coronavirus pandemic. Appearing in this video (in order) are:
• Mike Clayman, M.D., CEO, Flexion Therapeutics • Caroline Loew, Ph.D., CEO, Glympse Bio • Leen Kawas, Ph.D., Pharm.D., CEO, Athira Pharma • Rachel Leheny, Ph.D., CEO, CalciMedica